This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Janos Kodra, PhD
Principal Scientist, Research Chemistry at Novo Nordisk A/S


Janos T. Kodra graduated from the chemistry department at the Swiss Federal Institute of Technology (ETH) in Zürich in 1999 under the supervision of Prof. Dr. Steven A. Benner. He joined Novo Nordisk A/S in Copenhagen Denmark in 1998. He is author and co-author of a number of publications, book chapter and patents/patent applications in the field of medicinal chemistry, bioinformatics, therapeutic proteins and peptides. His current research interest covers the combination of synthetic organic chemistry with expressed proteins and synthetic peptides in order to develop new biological entities for the treatment of metabolic disorders.

Agenda Sessions

  • Design of a Potent Apelin Receptor Agonist with a Long in vivo Circulating Half-life